MedTrace Logo

Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome

NCT01946659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 344

Last updated 2015-09-11

No results posted yet for this study

Summary

This is a randomized controlled Trial to evaluate effect of a culturally and linguistically tailored, telephone-delivered behavioral intervention on adherence to recommended assessment and treatment of sleep apnea in Blacks with Metabolic Syndrome. The investigators believe low awareness of Sleep Apnea and the risk it imposes to an individual health plays an important role in underdiagnosis and low adherence to treatment among Blacks. Hence, culturally and linguistically tailored health education will decrease the knowledge gap and improve adherence to recommended assessment and treatment of sleep Apnea. the investigators believe the effect of adherence to treatment of Sleep apnea is shown to improve the components of Metabolic syndrome and hence promote well control of Hypertension, Diabetes, weight, triglyceride and cholesterol.

Conditions

Interventions

BEHAVIORAL

Adherence to Sleep Apnea Treatment

A health education material prepared after focus group discussion with community leaders and patients would be administered to the participants with an experienced health educator through phone. Upto 10 calls per each patient will be made to either group until 6 months or the patient has a sleep test done.

OTHER

Standard Care Group

The standard care group gets a standard print communications about sleep apnea produced by NLHBI and American Academy of Sleep Medicine

Sponsors & Collaborators

  • State University of New York - Downstate Medical Center

    collaborator OTHER

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Girardin Jean-Louis, PhD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946659 on ClinicalTrials.gov